INTRODUCTION
Although U.S. health care workers face a variety of occupational health and safety hazards, one of the most serious is exposure to blood-borne pathogens through needlesticks. [1] [2] [3] [4] [5] [6] The estimate of 600,000-800,000 needlesticks per year (400,000 in hospitals) is approximately double the actual reports of these occurrences, most of which involve hollow-bore needles. [7] [8] [9] The rates of infection following a contaminated needlestick from a source patient average 0.3% for human immunodeficiency virus, 10,11 1.8% (with a range of 0-7%) for hepatitis C, 12, 13 and 6-30% for hepatitis B. 14 Government agencies addressed this risk with exposure prevention guidelines and an Occupational Safety and Health Administration (OSHA) standard that emphasized engineering, administrative, and work practice control measures such as using sharps containers, providing training, providing immunization for hepatitis B, and prohibiting the recapping of needles. [15] [16] [17] When more recent prevention activities focused on the development of engineered sharps injury protections (ESIPs)-devices that incorporate active or passive mechanisms to help prevent needlestick injuries-OSHA revised its standard to mandate that health care workplaces evaluate ESIPs. 18, 19 Initial evidence suggests that using ESIPs reduces the risk of needlestick injuries; [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] the Government Accounting Office estimates that this reduction is as great as 29%. 30 The actual rate of adoption of ESIPs in U.S. hospitals by type of device, however, and the factors associated with adoption remained unknown. To investigate these vital aspects of risk reduction, we analyzed survey data collected for a larger study of a random sample of U.S. hospitals. Our hypothesis was that ESIP adoption would correlate positively with an increase in positive perceptions about ESIP characteristics (including perceived cost), the number of sources of information about needlestick injuries used by hospital training and infection control specialists, and the magnitude and level of social system support for use of ESIPs. These are the same types of factors that influence the rate of adoption of a variety of workplace innovations. [31] [32] [33] 
METHODS

Sample
Data for this study came from a survey that was used to evaluate the impact of a publication, NIOSH Alert: Preventing Needlesticks in Healthcare Facilities, 34 that had been mailed to the Directors of Infection Control or to the Directors of In-service Training at all 6,038 acute care U.S. hospitals with such personnel. A random sample of these hospitals was chosen for contact by trained telephone interviewers from November 1999 through February 2000. The total number of hospitals in the sample (668) was split evenly; then either the Director of Infection Control or the Director of In-service Training was the respondent; an additional sample of 67 hospitals (10%) was drawn in which both types of Directors were respondents. The Human Subjects Review Board of the National Institute for Occupational Safety and Health (NIOSH) approved this research, and respondents gave their informed consent before participating in the interviews.
Measures
All survey questions required closed-ended responses; some were dichotomous (yes/no), others involved a four-point, Likert-type response (strongly agree, agree, disagree, and strongly disagree). We used 31 survey items for this secondary analysis, selected from the 57 collected in the main study. The items we used included: (a) respondent characteristics (occupation, length of service, and frequency of use of ESIPs at work); (b) facility characteristics (number of beds, profit/nonprofit status, number of staff positions devoted to occupational safety and health, and whether the hospital is part of a larger organization; union status was also measured, but this variable was poorly operationalized, making the data unusable); (c) the status of state legislative activity on needlesticks; (d) the extent of use in appropriate units of safety blood collection needles, safety vacuum tube holders, winged steel needles, safety intravenous (IV) catheters, needleless IV delivery systems, protected needle IV systems, hypodermic syringes with a safety syringe, and hypodermic syringes with a safety needle; (e) attitudes about the efficacy of ESIPs, their effect on patient care, their cost, and their availability; and (f ) whether the respondent remembered receiving information about needlestick injuries from peer-reviewed journals, the State Health Department, medical device manufacturers, the American Hospital Association's (AHA's) guide on needlestick injuries, local newspapers, trade magazines, training or education, OSHA, the Internet, internal policy memos, and NIOSH.
Public Health Reports / July-August 2002 / Volume 117 To arrive at the average extent of adoption of ESIPs, we constructed an overall ESIP use scale by assigning points for each use response option (none = 0, few units = 1, most units = 2, all units = 3) and coding "don't know" responses as "missing." Because they could substitute for each other, we totaled the highest of the scores given for the two blood collection devices, the two IV delivery systems, and the two hypodermic syringes before adding the scores for the safety IV catheter and the winged steel needle. We then divided this sum by the total number of devices for which data were complete.
To determine the total sources of information, we simply added positive responses.
To determine the factors associated with the likelihood of a facility adopting ESIPs, we conducted bivariate correlation and multiple regression analysis 35 to reveal the association between the overall measure of adoption of ESIPs and 10 variables: the four measures of perceived characteristics of ESIPs, the total number of sources of information, the four facility characteristics, and the extent of recent needlestick legislation at the state level.
Using multiple regression, we analyzed adoption of ESIPs using a linear combination of these 10 variables plus a set of four dummy variables representing "don't know" responses. 36 We then reviewed beta weights (standardized multiple regression coefficients) and squared semipartial correlations (the percentage of variance accounted for by a single predictor beyond that accounted for by the other predictors) to assess the relative importance of each of our 10 variables in the prediction of adoption of ESIPs.
We applied logistic regression analysis to identify which factors predict a respondent's knowledge about ESIP use in the facility, assigning the dependent variable one code for no such knowledge and another if the respondent knew the extent of adoption of at least one ESIP. For this analysis, we added years of tenure in the present position to our independent variables.
Because the information sources variable was a composite of 11 possible media, we conducted both bivariate correlation and multiple regression to estimate which sources were associated with ESIP use. We also conducted a multiple regression analysis to determine the impact on adoption of the composite variable.
Finally, to check our random selection procedures, we compared data from our sample to national data on community hospitals collected by the AHA for facility size (number of beds), profit/nonprofit status, and state legislative activity. 37 
RESULTS
Respondent characteristics
Of the original sample of 802 respondents, we were able to contact 762 (some facilities or individuals were unreachable by telephone because of closing, merger, or other factors). Of these, 68% (518 respondents from 494 hospitals) participated in the survey. The respondents intentionally surveyed for a within-hospital concurrence check provided substantially similar responses (these results are available from the first author). In these cases, we randomly chose the data from one of the two respondents from the same hospital for inclusion in the overall analysis. Of the 494 separate hospital surveys collected from 48 states, 465 provided complete data for all variables.
Of the respondents, 52% were Directors of Infection Control, 46% were Directors of In-service Training, and 2% occupied both roles. Approximately 67% had held their current position for at least three years, 44% for at least five years, and only 12% for less than one year. Fifty-three percent indicated that they "often" or "sometimes" used a needle-bearing device in their work.
Facility characteristics
The median facility size for our sample was 100 beds (range 0-1,800, mean 164.5, SD 188.0). Most (81%) of the facilities were nonprofit, and nearly half (49%) were affiliated with a larger organization. The number of people with jobs related to employee safety and health was five or more in 46% of the hospitals, three to four in 21%, and two or fewer in 26%.
State legislative activity
All data were collected prior to the adoption of the federal Needlestick Prevention Act. The states with needlestick legislation (California, Tennessee, Maryland, and Texas) were represented by 19% of the sample, and another 28% were from 1 of the 16 states considering such legislation.
Hospital ESIP adoption and needlestick injury surveillance
Almost all respondents (96%) reported that their facility was analyzing needlestick injury data, and 74% of these indicated that this activity started at least three years ago (62% at least five years ago). Three percent (14) of the respondents reported that an employee in their facility had been infected with a blood-borne pathogen during the past year.
Most of the sample (408; 83%) reported that their facility used at least some ESIPs. As Table 1 illustrates, use of specific ESIPs by all appropriate units in the facility ranged from 12% (hypodermic syringes with safety needles) to 52% (needleless IV delivery systems). Sixty-three percent reported adoption of the needleless IV delivery system in at least a few of the appropriate units. The next most frequently used ESIP was the safety IV catheter, followed by the safety vacuum tube holder, blood collection devices with safety needles, protected needle IV delivery systems, hypodermic syringes with safety syringes, winged steel needles, and hypodermic syringes with safety needles. For every device, more than a quarter of the sample reported that none of the appropriate units were using the device. 
Attitudes about ESIPs
Of the four items that tapped perceived characteristics of ESIPs, the greatest agreement was among the 95% of respondents who believed that use of ESIPs did not reduce the quality of patient care ( Table 2 ). In addition, most respondents thought that use of ESIPs would reduce the frequency of needlesticks among health care workers in their facility. However, respondents were almost evenly divided about whether their hospital would have difficulty with the cost of ESIPs. Although 55% thought that the availability of ESIPs was not a problem, 24% thought it was (20% reported "don't know"). 
Sources of information about needlesticks
The most often cited sources of information on needlestick injuries were training and education (92%), manufacturers' literature (88%), internal policy memos (86%), OSHA (85%), trade magazines (78%), peerreviewed journals (74%), and NIOSH (72%). Less frequently cited were State Health Departments (59%), the AHA guide (55%), the Internet (55%), and local newspapers (29%). Most respondents (86%) reported receiving needlestick information from multiple sources (more than five of the 11 possible sources), and 74% reported exposure to seven or more sources (mean 7.74, SD 2.10).
Factors associated with adoption of ESIPs
The two predictor variables that the bivariate correlations revealed to be significantly related to adoption of ESIPs are lack of organizational concern about the cost of ESIPs (r = 0.30) and number of beds (r = 0.18). These correlations are significant at the pϽ0.0009 level (pϽ0.05/55 comparisons; Bonferroni correction), and both are in the predicted direction ( Table 3 ). The multiple regression of adoption of ESIPs on the variables and the dummy variables accounts for 18% of the variance (unadjusted) in adoption [F (14, 450) 
The beta weight review revealed that the only variables related to ESIP use are perceived organizational concern about the cost of ESIPs, needlestick legislative activity at the state level, and facility size ( Table 4) . Organizational concern about the cost of ESIPs is a much stronger predictor than any other variable (standardized beta = 0.30, pϽ0.0001), because respondents who believed that cost was not a problem for their hospital reported more extensive ESIP use than did those who were concerned about cost. Although ESIP use increased as facility size and state legislative activity variables increased, their association with ESIP use is only about half as strong as perceived cost (standardized betas = 0.19 and 0.15; pϽ0.001).
The squared semipartial correlations for these variables matched the beta weight findings, with cost accounting for about 8% of the variance in ESIP use beyond that accounted for by the other nine predictors (F (1, 450) = 44.36, pϽ0.0001). Facility size and legislative activity accounted for about 3% and 2% of independent variance (F (1, 450) = 17.19 and 11.10, pϽ0.001).
Approximately 6% (29) of the respondents did not know whether their hospital used any of the eight ESIPs. Logistic regression revealed that, as a group, the independent variables make a significant contribution to the prediction of knowledge about facility ESIP usage (x 2 = 44.12, df = 15, pϽ0.0001). When considered individually, however, only facility size and sources of information are significant predictors of such knowledge (Wald x 2 = 8.11 and 8.96, pϽ0.005). As expected, the standardized beta for sources of information was negative (-0.32), indicating that respondents with more sources of information are more likely to have information about ESIP usage at their facility. Respondents in larger hospitals are more likely to lack knowledge about ESIP usage (standardized beta = 0.24).
The bivariate correlations revealed that the needlestick coverage in internal policy memorandums or newspapers is associated with greater ESIP use (r = 0.13, pϽ0.01; r = 0.11, pϽ0.02). The other sources of information are not significant predictors at the pϽ0.05 level. Multiple regression of adoption of ESIPs on the 11 information sources suggested that none of these variables are significant predictors of ESIP use (F (11, 453) = 1.63, pϾ0.05).
Comparison of sample characteristics
We found no significant differences between our sample and an AHA national sample for facility size (x 2 = 7.24, df = 7), profit/nonprofit status (x 2 = 0.74, df = 1), and state legislation status (x 2 = 1.60, df = 2, smallest p=0.08). This supports the success of our randomization procedures and the generalizability of our results to the national level.
DISCUSSION
Although efforts are underway to assess the extent of needlestick injuries and blood-borne pathogen exposure incidents in a continuous fashion, we know of no other national data that estimates the extent of adoption of ESIPs or, indeed, of other protective measures.
Information sources
Although our respondents had many sources of information about needlestick injuries, they most frequently cited in-house training. This may be partly because of the mandatory training provisions of OSHA's bloodborne pathogens standard. The fact that most respondents also cited internal policy memos, however, indicates that employers are taking their vital role in hazard communication seriously, at least at the professional level of our respondents.
Industry sources also appear to be important sources of information. Thus, manufacturers have a role in providing information about the hazards their devices are intended to minimize. That respondents cited OSHA and NIOSH more frequently than their state health departments as sources of information may be Public Health Reports / July-August 2002 / Volume 117 Table 3 . Variable means, standard deviations, correlation coefficients (ϫ100) partly attributable to the fact that OSHA's compliance directive and NIOSH's needlestick alert were both issued immediately before the survey. 34, 38 It may also be possible that State Health Departments occupy a less prominent role in occupational health surveillance and regulation. Future research may profitably examine the relative role of various federal, state, and local government agencies in providing information, surveillance, and enforcement to protect health care workers from occupational hazards.
Intercorrelations
Attitudes about ESIPs
Of the four perceptions about ESIP characteristics we examined, perceived high cost was by far the most often selected negative characteristic. This may reflect the fact that early versions of most new technologies are often expensive, because manufacturers attempt to recoup product development costs as quickly as possible. The costs associated with occupationally acquired blood-borne pathogen infection, however, can also be substantial. The currently available cost-benefit analyses of ESIPs consider a varying range of costs and, thus, differ substantially in their conclusions. 30, 39, 40 Perceptions about the cost-benefit ratio of ESIP use may become more realistic when hospitals include the long-range medical, legal, social, and ethical implications of needlestick injuries in their analyses. Our respondents agreed that ESIPs would reduce occupational injuries, while not adversely affecting quality of patient care, indicating that the perceived efficacy of ESIPs or patient care concerns are not barriers to adoption.
Adoption of ESIPs and factors associated with adoption
Although most of our respondents reported some level of adoption of ESIPs, adoption was not universal. Safer IV delivery systems were adopted most frequently, perhaps because they were the first category of ESIPs to be developed (partially in response to a 1992 safety alert from the Food and Drug Administration 41 ). They are easy to use, and needlestick injuries are extremely common with traditional IV systems, thus providing motivation to change technologies among clinical workers.
We hypothesized that four characteristics of ESIPs would predict adoption, but only high cost correlated with (non) adoption. This was the most important factor by far, explaining more than three times the percentage of unique variance in ESIP adoption than any other factor. This is at odds with the results of a meta-analysis that found that many aspects of an innovation, including time savings, ease of operation, and rate of cost recovery are important predictors of inno-vation adoption. 33 Because ESIP availability, effectiveness, and impact on patient care were not related to adoption, it appears that hospitals may be allowing the perceived cost of safety innovations to influence the level of protection they provide to their employees.
However, it is noteworthy that Government Accounting Office estimates of the per-bed costs of ESIPs list the increased cost of safety IV catheters over conventional devices at approximately $77 per bed per year. In contrast, the increased cost of safety blood collection devices is $48 and that of hypodermic syringes is approximately $40 more per bed per year. 30 Thus, it is more expensive to adopt safety IV catheters than other ESIPs, yet that is the more common decision. This important finding may reflect a factor that is unique to the adoption of innovations designed solely to reduce risk: it is possible that administrators will apply limited funds first to the particular ESIP that they believe will result in the greatest risk reduction, regardless of whether that device is the most expensive of such risk reduction choices. Clearly, more things influence ESIP adoption than simply cost, and the factors of time since introduction, new ESIP developments, and increased product availability may also prove to be important.
Previous studies have shown the vital role of both internal and external communications in the success of innovations diffusion. 42 Our analysis found that newspapers were the least-cited source of information about needlesticks, and the multiple regression model using all information sources to predict ESIP usage was not significant. This may be explained by the fact that our measure asked whether or not the respondent remembered seeing anything on needlestick injuries rather than on ESIPs, and the diffusion of innovations model specifies that communications must be about the innovation to be effective. Our data did reveal, however, that those who were exposed to more information sources on injuries were also more likely to have knowledge about ESIP adoption. This finding indicates that information dissemination may be an important component of the adoption process, because exposure to information about a health problem is associated with knowledge about a major solution to the problem.
Our finding that hospital size correlates positively with ESIP adoption agrees with previous reports that organization size is one of the most consistent predictors of innovation adoption. [43] [44] [45] [46] Economies of scale make it easier to adopt innovations. In addition, larger hospitals may have more human resources to institute changes, more purchasing power to control prices, greater exposure to new ideas, and more resources to survive failed ideas-any and all of which could con-tribute to a greater willingness to try innovations. Thus, smaller institutions may need special encouragement and assistance from other sources to adopt the same innovations.
We found that hospitals are more likely to adopt ESIPs if they are located in a state where the legislature was considering or had passed a needlestick prevention bill. Our measure of this factor was very crude, however, because such legislation varies widely in regard to what was (or would be) required of hospitals. In addition, the majority of states taking action were only considering legislation at the time of the survey. Nevertheless, our data are consistent with the idea that regulation has a role in effective prevention efforts. Since the time our data were collected, new federal law requires evaluation of ESIPs at every health care facility covered by federal safety law. 19 Thus, regulations may now play a larger role in ESIP adoption.
Efforts to increase the adoption of ESIPs should clearly include strategies to increase estimations of their cost-benefit among health care workers, but other factors should be addressed as well. Together, all of the independent variables examined in our study explained only a small portion of the variance in ESIP adoption. As more and more ESIP products come onto the market, future research should focus on the influence of such factors as innovation compatibility with existing situations, advantage over existing products or methods, and innovation complexity on ESIP adoption. These were all factors that a meta-analysis of 75 innovation diffusion studies found had the most consistently significant relationship to innovation adoption. 33 Future research might also examine the relative importance of government regulations (local, state, and federal) and hospital certification standards in adoption rates. Additional social influences (e.g., interorganizational visibility and leadership) 47 should also be investigated. Although ESIPs are the mandated and preferred method to protect health care workers from needlesticks, they will achieve adoption faster with the support of the social systems in which they are used and with the support of the people who use them.
Study limitations
Our study had several limitations. First, its crosssectional nature prohibits conclusions about causation, such as whether positive attitudes toward ESIPs and increased legislative activity lead to greater adoption of ESIPs or vice versa, or about the effects of time, an important predictor of innovations diffusion. 42 In addition, we analyzed individual-level data at the organizational level. Employees with different backgrounds or responsibilities than the respondents may have pro-vided different responses. Our data are also subject to a social desirability bias, because respondents were informed that NIOSH, an organization they may have known favors ESIP adoption, was conducting the study. This may have led respondents to inflate positive perceptions of ESIPs and reports of their use.
